rituximab,cyclophosphamide
biogen,roche
['ritux', 'cyclophosphamide', 'imab ']
 subgroup analysis of recital by disease groups from shows some benefit of rituximab over cyclophosphamide on fvc in patients with myositis, and improved mrss is patients with systemic sclerosis. #acr22 plenary 
The #LancetRheumatology is a clinical #rheumatology journal publishing innovative & practice-changing research & opinion across all #rheumatic & #MSK disorders